Plasminogen activating capacity in gingival fluid from deteriorating and stable periodontal pockets

Journal of Periodontal Research

Volumn 37, Issue 1, 2002, Pages 60-65

  Olofsson, Anna ^a   Matsson, Lars ^a   Kinnby, Bertil ^a  

^a MALMÖ UNIVERSITY   (Sweden)

Author keywords

Gingival fluid; Periodontitis; Plasminogen activation; Proteolysis

Indexed keywords

PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 2; SERINE PROTEINASE INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVITIS; HUMAN; MALE; METABOLISM; MICROPORE FILTER; MIDDLE AGED; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PERIODONTITIS;

AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; MALE; MICROPORE FILTERS; MIDDLE AGED; PERIODONTAL POCKET; PERIODONTITIS; PLASMINOGEN ACTIVATOR INHIBITOR 2; PLASMINOGEN ACTIVATORS; SERINE PROTEINASE INHIBITORS; STATISTICS, NONPARAMETRIC; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0036481663     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0765.2002.00325.x     Document Type: Article

References (31)

1. Ossowski L, Reich E. Antibodies to plasminogen activator inhibit human tumor metastasis. Cell 1983;35 611-619.
2. Andreasen PA, Kjøller L, Christensen L, Duffy MJ. The urokinase-type plasminogen activator system in cancer metastasis.a review. Int J Cancer 1997;72:1-22.
3. Reuning U, Magdolen V, Wilhelm O et al. Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review), Int J Oncol 1998;13:893-906.
4. Werb Z, Mainardi CL, Vater CA, Harris ED Jr. Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. New Engl J Med 1977:296:1017-1023.
5. Danø K, Andreasen P, Grøndahl-Hansen J, Kristensen P, Nielsen LS. Skriver L. Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 1985;44:139-266.
6. Saksela O. Plasminogen activation and regulation of pericellular proteolysis. Biochim Biophys Acta 1985;823:35-65.
7. Åstedt B. No cross reaction between circulating plasminogen activator and urokinase. Thromb Res 1979,14:535-539.
8. Danø K, Rømer J. Nielsen BS, Pyke C, Rygaard J, Lund L. Cancer invasion and tissue remodelling - cooperation of protease systems and cell types. Review article. APMIS 1999;107:120-127.
9. Åstedt B, Hägerstrand I, Lecander I. Cellular localisation in placenta of placental type plasminogen activator inhibitor. Thromb Haemost 1986;56:63-65.
10. Kruithof EKO, Baker MS, Bunn CL. Biological and clinical aspects of plasminogen activator inhibitor type 2. Blood 1995;86:4007-4024.
11. Kinnby B. Plasminogen activators and their specific inhibitors in human gingival crevicular fluid. Thesis, Lund University. Sweden 1995. ISBN 91-628-1817-1.
12. Kinnby B, Lindberg P, Lecander I, Matsson L. Localization of plasminogen activators and plasminogen-activator inhibitors in human gingival tissues demonstrated by immunohistochemistry and in situ hybridization. Arch Oral Biol 1999;44:1027-1034.
13. Kinnby B, Lecander I, Martinsson G, Åstedt B. Tissue plasminogen activator and placental plasminogen activator inhibitor in human gingival fluid. Fibrinolysis 1991: 5:239-242.
14. Kinnby B, Matsson L, Lecander I. The plasminogenactivating system in gingival fluid from adults. An intraindividual study before and after treatment of gingivitis. Scand J Dent Res 1994;102:334-341.
15. Kinnby B, Borgström MK, Granath L, Lecander I, Sundin B. Tissue plasminogen activator (t-PA) and placental plasminogen activator inhibitor (PAI-2) in gingival fluid from 8-9-year-old children. Scand J Dent Res 1993; 101:279-281.
16. Kinnby B, Matsson L, Åstedt B. Aggravation of gingival inflammatory symptoms during pregnancy associated with the concentration of plasminogen activator inhibitor type 2 (PAI-2) in gingival fluid. J Periodont Res 1996;31:271-277.
17. nd edn. Malmö: Odonlo Science. 1995.
18. Lindhe J, Nyman S. Long-term maintenance of patients treated for advanced periodontal disease. J Clin Periodontol 1984;11:504-514.
19. Loe H, Anerud A, Boysen H, Morrison E. Natural history of periodontal disease in man. Rapid, moderate and no loss of attachment in Sri Lankan laborers 14 to 46 years of age. J Clin Periodontol 1986;13:431-440.
20. Birkedal-Hansen II. Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 1995;7:728-735.
21. Lecander I. Åstedt B. Specific plasminogen activator inhibitor of placental type PAI-2 occurring in amniotic fluid and cord blood. J Lab Clin Med 1987;110:602-605.
22. Masada MP, Persson R, Kenney JS, Lee SW, Page RC, Allison AC. Measurement of interleukin-lα and -1β in gingival crevicular fluid: implications for the pathogenesis of periodontal disease. J Periodont Res 1990;25:156-163.
23. Wilton JMA, Bampton JLM, Griffiths GS et al. Interleukin-1 beta (IL-1β) levels in gingival crevicular fluid from adults with previous evidence of destructive periodontits. A cross-sectional study. J Clin Periodontol 1992;19:53-57.
24. Hou LT, Liu CM, Rossomando EF. Crevicular interleukin1β in moderate and severe penodontitis patients and the effect of phase I periodontal treatment. J Clin Periodontol 1995;22:162-167.
25. Saxne T, Lecander I, Geborek P. Plasminogen activators and plasminogen activator inhibitors in synovial fluid Difference between inflammatory joint disorders and osteoarthritis. J Rheumatol 1993;20:91-96.
26. Page RC, Beck JD. Risk assessment for periodontal disease. Int Dent J 1997;47:61-87
27. Allen RA, Kluft C, Brommer EJ. Acute effect of smoking on fibrinolysis: increase in the activity level of circulating extrinsic (tissue-type) plasminogen activator. Eur J Clin Invest 1984;14:354-361.
28. Haire WD, Goldsmith JC, Rasmussen J. Abnormal fibrinolysis in healthy male cigarette smokers: role of plasminogen activator inhibitors. Am J Hematol 1989;31:36-40.
29. Gleerup G, Winther K. Smoking further increases platelet activity in patients with mild hypertension. Eur J Clin Invest 1996;26:49-52.
30. Simpson AJ, Gray RS, Moore NR, Booth NA. The effects of chronic smoking on the fibrinolytic potential of plasma and platelets. Br J Haematol 1997;97:208-213.
31. Kjædgaard A, Larsson B. Long-term treatment with combined oral contraceptives and cigarette smoking associated with impaired activity of tissue plasminogen activator. Acta Obstet Gynecol Scand 1986;65:219-222.